跳至主要内容
临床试验/CTRI/2024/08/072349
CTRI/2024/08/072349尚未招募2/3 期

A comparative clinical study to evaluate the efficacy of Krishna Tila Kashaya and Kulatthadi Kashaya in the management of Artavakshaya

Rajiv Gandhi University of health sciences1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年8月26日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
30
试验地点
1
主要终点
The study reveals that Krishna tila Kashaya and kulatthadi kashaya effectively reduces pain, increases duration of flow, increases menstrual bleeding, reduces duration of inter menstrual period, regulates harmones and improves quality and quantity of arthava.

研究概览

简要总结

A comparative clinical study to evaluate the efficacy of Krishna Tila Kashaya and Kulatthadi Kashaya in the management of Arthavakshaya, between the age group of 18-35 years. During the study period 30 patients will be recruited and divided into 2 groups. Group A (Control) with oral administration of Krishna Tila Kashaya - 40ml BD dosage with Anupana 6gm of Guda B/F and Group B (trial) with oral administration of Kulatthadi Kashaya - 10ml BD dosage with Anupana 30 ml of Ushna jala B/F except on the days of menstruation. Statistical analysis will be done on Baseline and 3 months of menstrual  cycle.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • 1.Patients aged between 18-35 years.
  • 3.Bleeding, spotting less than 2 days.
  • 4.Pad used 1 per day.
  • 5.Infrequent menses at intervals longer than 35 days.
  • 6.Patients presenting with the Pratyatma Lakshana of Artava Kshaya.
  • (Uchitakala Adarshana, Alpata, Yonivedana).

排除标准

  • 1.Patient with a systemic disorder like DM, HTN, TB, Asthma, Congenital abnormalities.
  • 2.Patient with mal-nutrition, severe anaemia (Hb less than 8gm percent) pregnant and Lactating women, women using OCP and IUCD, congenital anomalies of uterus or ovaries.

结局指标

主要结局

The study reveals that Krishna tila Kashaya and kulatthadi kashaya effectively reduces pain, increases duration of flow, increases menstrual bleeding, reduces duration of inter menstrual period, regulates harmones and improves quality and quantity of arthava.

时间窗: Baseline, 3 months

The research underscores the importance of adopting simple, cost effective management stratagies for arthava kshaya, reduce health care costs, improve access to care for underserved populations, and enhance overall quality of life.

时间窗: Baseline, 3 months

次要结局

  • The study emphasizes the significance of identifying alleviating factors(upashaya) in clinical practice, enabling clinicians to design personalized treatment plans that target the root cause of arthava kshaya.(As a result of normalizing arthavavaha sroto avarodha, fertility can also be improved in patients desiring fertility, regularity of further menstrual cycle)

研究者

申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Sneha D V

SDM Institute of Ayurveda and Hospital, Anchepalya, Bangalore, Karnataka,560074,India.

研究点 (1)

Loading locations...

相似试验